期刊文献+

非酒精性脂肪肝与生长激素相关性研究 被引量:1

Relationship between nonalcoholic fatty liver disease and growth hormone
下载PDF
导出
摘要 目的探讨非酒精性脂肪肝(NAFLD)与生长激素(GH)的关系。方法入选NAFLD组38例,非NAFLD组42例,测定GH、腰围(WC)、空腹血糖(FPG)、空腹胰岛素(FIns)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、高敏C反应蛋白(hs-CRP),谷氨酸氨基转移酶(ALT)、γ-谷氨酰转肽酶(GGT)水平,计算体质量指数(BMI)、胰岛素抵抗指数(HOMA-IR)。结果 NAFLD组GH、HDL-C水平显著低于非NAFLD组(P<0·05);NAFLD组BMI、WC、FPG、FIns、HOMA-IR、TG、hsCRP、ALT、GGT水平显著高于非NAFLD组(P<0·05)。GH、HDL-C与NAFLD呈负相关,WC、BMI、FPG、FIns、HOMA-IR、TG、hsCRP、ALT、GGT与NAFLD呈正相关。结论 GH与NAFLD密切相关,低水平GH可能是NAFLD危险因素,与肥胖、胰岛素抵抗、血脂紊乱等共同参与了NAFLD的发生与发展。 Objective To explore the relationship between non-alcoholic fatty liver disease (NAFLD) and growth hormone (GH). Methods Thirty-eight patients with NAFLD, 42 patients without NAFLD were enrolled in this study. The levels of waist circumference (WC), serum growth hormone (GH), fasting plasma glucose (FPG), fasting insulin ( Fins), total cholesterol( TC), triglyeeride ( TG), high density lipoprotein cholesterol ( HDL-C ), low-density lipoprotein cholesterol(LDL-C) , high sensitivity C reactive protein(hsCRP) , alanine aminotransferase (ALT) , gamma glutamyltransferase(GGT) were measured. Body mass index (BMI) and insulin resistance index (HOMA-IR) were calculated. Resuits In NAFLD group, the levels of GH and HDL-C were significantly lower than those in non-NAFLD group ( P 〈 0. 05) ;In NAFLD group, the levels of WC, BMI, FPG, Fins, HOMA-IR, TG, hsCRP, ALT, GGT were significantly higher than those in non-NAFLD group. The levels of GH and HDL-C were negatively correlated with NAFLD. The levels of WC, BMI, FPG, Fins, HOMA-IR, TG, hsCRP, ALT, GGT were positively correlated with NAFLD. Conclusions GH is closely related with NAFLD. Low-level GH may be a risk factor for NAFLD and may participate in the occurrence and development of NAFLD.
出处 《实用老年医学》 CAS 2011年第4期333-335,共3页 Practical Geriatrics
关键词 非酒精性脂肪肝 生长激素 non-alcoholic fatty liver disease growth hormone
  • 相关文献

参考文献5

二级参考文献60

  • 1Fan, Jian-Gao,Peng, Yong-De.Metabolic syndrome and non-alcoholic fatty liver disease:Asian definitions and Asian studies[J].Hepatobiliary & Pancreatic Diseases International,2007,6(6):572-578. 被引量:42
  • 2胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 3Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM, Zhao ZY. Prevalence of the metabolic syndrome in Zhejiang Chi- nese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes (Lond) 2007; 31:15-22.
  • 4Osawa H, Mori Y. Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes. J Clin Ultrasound 1996; 24:25-29.
  • 5Yajima Y, Ohta K, Narui T, Abe R, Suzuki H, Ohtsuki M. U1- trasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med 1983; 139:43-50.
  • 6Gallagher EJ, LeRoith D, Karnieli E. The metabolic syndrome-from insulin resistance to obesity and diabetes. En- docrinol Metab Clin North Am 2008; 37: 559-579, vii.
  • 7Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes (Lond) 2008; 32:381-387.
  • 8Calcaterra V, Klersy C, Muratori T, Telli S, Caramagna C, Scaglia F, Cisternino M, Larizza D. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf) 2008; 68:868-872.
  • 9Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115:e561-e565.
  • 10Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43:S99-S112.

共引文献1595

同被引文献11

  • 1Ahima RS,Flier JS.Leptin[].Annual Review of Physiology.2000
  • 2Yu AS,Keeffe EB.Nonalcoholic fatty liver disease[].Reviews in Gastroenterological Disorders.2002
  • 3Xu A,Wang Y,Keshaw H,et al.The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice[].The Journal of Clinical Investigation.2003
  • 4Marchesini G,Marzocchi R,Agostini F,et al.Nonalcoholic fatty liver disease and the metabolic syndrome[].Current Opinion.2005
  • 5Fantuzzi G.Adipose tissue, adipokines, and inflammation[].Journal of Allergy and Clinical Immunology The.2005
  • 6Farrell GC,Chitturi S,Lau GK,et al.Asia-Pacific Working Party onNAFLD.Guidelines for the assessment and management of nonalcoholicfatty liver disease in the Asia-Pacific region:executive summary(J)[].JGastroenterol Hepatol.2007
  • 7Cheung O,Sanyal AJ.Recent advances in nonalcoholic fatty liver disease[].Current Opinion in Gastroenterology.2009
  • 8Pagano,C,Soardo,G,Esposito,W,Fallo,F,Basan,L,Donnini,D.Plasma adiponectin is decreased in nonalcoholic fatty liver disease[].European Journal of Endocrinology.2005
  • 9Sweeney G,Keen J,Omwar R,et al.High1eptin levels a-cutely inhibit insulin-stimulated glucose uptake without af-fecting glucose transporter4translocation in16rat skeletal muscle cells[].The Journal of Endocrinology.2001
  • 10张日华.合并脂肪肝高血压病患者大动脉顺应性改变与胰岛素抵抗的相关性[J].现代医院,2010,10(6):39-41. 被引量:4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部